Stay Up to Date
Featured News
FDA APPROVES OGSIVEO™ (NIROGACESTAT), AS THE FIRST MEDICAL THERAPY FOR THE TREATMENT OF ADULTS WITH PROGRESSING DESMOID TUMORS.
Filter by:
September 26, 2023
DTRF Press Release: The Desmoid Tumor Research Foundation Announces That Groundbreaking Results From The Phase 3 Springworks Defi Trial Were Published Today In The New England Journal Of Medicine (More)
June 12, 2023
Coverage of Desmoid Tumors at ASCO 2023
May 21, 2023
Top 5 Reasons To Attend The Annual DTRF Together We Will Weekend
Read More about Top 5 Reasons To Attend The Annual DTRF Together We Will Weekend
May 9, 2023
NCI Article, “Nirogacestat May Offer Hope To People With Desmoid Tumors”
Read More about NCI Article, “Nirogacestat May Offer Hope To People With Desmoid Tumors”
April 3, 2023
What’s New with the DTRF Together We Will Weekend?
Read More about What’s New with the DTRF Together We Will Weekend?
March 7, 2023
DTRF Announces The First Publicly Available Desmoid Tumor Immortal Cell Line
Read More about DTRF Announces The First Publicly Available Desmoid Tumor Immortal Cell Line
